- Home
- RNXT vs LPAA Comparison
RNXT vs LPAA Comparison
Compare RNXT & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.80
Company Overview
Basic Information| Metric | RNXT | LPAA |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 81.4M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RNXT | LPAA |
|---|---|---|
| Price | $1.80 | $10.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | N/A |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $10.44 |
| 52 Week High | $2.59 | $11.67 |
Technical Indicators
Market Signals| Indicator | RNXT | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 46.59 |
| Support Level | $0.83 | $10.61 |
| Resistance Level | $2.59 | $10.79 |
| Average True Range (ATR) | 0.27 | 0.01 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 36.67 | 22.22 |
Price Performance
Historical Comparison RNXT
LPAA
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.